Cardioprotection against Heart Failure by Shenfu Injection via TGF-β/Smads Signaling Pathway

Figure 7

The effect of SFI treatment on myocardial pathology in rats with HE staining after 4 weeks. Notes. (a) Sham group, (b) HF model group, (c) Valsartan + HF group, (d) SFI 1.5 mL/kg + HF group, and (e) SFI 0.75 mL/kg + HF group. Bar, 100 μm. HF, heart failure; SFI, Shenfu injection; HE, hematoxylin-eosin.

(a)

(b)

(c)

(d)

(e)